Synthesis of 5-Arylmethyl-5-phenylimidazolidine-2,4-dione
Letters in Organic Chemistry, 2011, Vol. 8, No. 3
201
chalcone had disappeared as indicated by TLC. After
completion of the reaction, the mixture was poured into
water and filtered. The filtrate was neutralized to pH=5~6 by
3 mol/L hydrochloric acid and filtered. The solid was
washed with water (3ꢀ15 mL) and dried to give the product
3a.
129.2, 129.2, 128.8, 126.5, 125.9, 125.9, 113.9, 111.9, 72.0,
55.4, 42.9 ppm.
Compound 3i
5-(2-chlorobenzyl)-5-phenyl-2-thioxoimidazolidin-4-one
o
1
Yellow solid, m.p.202 C; m/z (ESI): 317 [M+H]+; H
NMR (DMSO): ꢁH 2.51-2.53 (1H, d, J=12 Hz, CH2), 3.71-
3.73 (1H, d, J=12 Hz, CH2), 7.25-7.60 (9H, m, Ar-H), 10.77
(1H, s, NH), 11.68 (1H, s, NH); 13C NMR (DMSO): ꢁC
181.7, 175.8, 137.9, 134.8, 132.6, 132.5, 129.9, 129.6, 129.2,
129.2, 128.9, 127.3, 126.6, 126.6, 71.5, 31.2 ppm.
The authenticity of the product 3b, 3c, 3d and 3g-j was
1
established by their H NMR, 13C NMR and MS, the rest
known compounds (3a, 3e and 3f) were established by their
melting points compared with that reported in literature [4, 9,
10].
Compound 3j
Compound 3b
5-(4-chlorobenzyl)-5-phenyl-2-thioxoimidazolidin-4-one
5-(2-methoxybenzyl)-5-phenylimidazolidine-2,4-dione
o
Yellow solid, m.p.202-204 C; m/z (ESI): 317 [M+H]+;
o
1
Yellow solid, m.p.185 C; m/z (ESI): 297 [M+H]+; H
NMR (DMSO): ꢁH 3.17-3.19 (1H, d, J=12 Hz, CH2), 3.44-
3.46 (1H, d, J=12 Hz, CH2), 3.73 (3H, s, OCH3), 6.83-7.63
(9H, m, Ar-H), 8.34 (1H, s, NH), 10.48 (1H, s, NH); 13C
NMR (DMSO): ꢁC 175.4, 157.8, 155.9, 139.6, 131.2, 128.5,
128.3, 128.3, 127.8, 125.6, 125.6, 123.1, 119.9, 110.8, 68.1,
55.3, 37.4 ppm.
1H NMR (DMSO): ꢁH 3.10-3.12 (1H, d, J=12 Hz, CH2),
3.51-3.53 (1H, d, J=12 Hz, CH2), 7.24-7.58 (9H, m, Ar-H),
10.81 (1H, s, NH), 11.69 (1H, s, NH); 13C NMR (DMSO): ꢁC
181.7, 175.9, 138.1, 138.1, 133.7, 132.6, 132.6, 129.3, 129.3,
128.9, 128.5, 128.5, 125.9, 125.9, 71.7, 42.7 ppm.
Compound 3c
ACKNOWLEDGEMENT
5-(4-methoxybenzyl)-5-phenylimidazolidine-2,4-dione
Yellow solid, m.p. 231-233 (206-208 [4]) oC; m/z (ESI):
The project was supported by Natural Science
Foundation of Hebei Province (B2006000969), China.
1
297 [M+H]+; H NMR (DMSO): ꢁH 2.91-2.93 (1H, d, J=12
Hz, CH2), 3.44-3.46 (1H, d, J=12 Hz, CH2), 3.73 (3H, s,
OCH3), 6.85-7.64 (9H, m, Ar-H), 8.64 (1H, s, NH), 10.44
(1H, s, NH); 13C NMR (DMSO): ꢁC 175.3, 158.3, 155.8,
139.4, 131.4, 128.4, 127.9, 126.6, 125.5, 113.4, 68.5, 54.9,
42.9 ppm.
REFERENCES
[1]
(a) Browne, T. R. Drug therapy reviews: drug therapy of status
epilepticus. Am. J. Hosp. Pharm., 1978, 35, 915; (b) Browne, T. R.
Drug therapy reviews: clinical pharmacology of antiepileptic drugs.
Am. J. Hosp. Pharm., 1978, 35, 1048.
[2]
[3]
Krall, R. L.; Penry, J. K.; White, B. G.; Kupferberg, H. J.;
Swinyard, E. A. Antiepileptic drug development: ii. Anticonvulsant
drug screening. Epilepsia, 1978, 19, 409.
Kashem Liton, A.; Rabiul Islaml, M. Synthesis of hydantoin and
thiohydantoin related compounds from benzyl and study of their
cycotoxicity. Bangladesh T. Pharmacol, 2006, 1, 10.
Compound 3d
5-(2-chlorobenzyl)-5-phenylimidazolidine-2,4-dione
o
Yellow solid, m.p.230-232 C; m/z (ESI): 301 [M+H]+;
1H NMR (DMSO): ꢁH 3.31-3.33 (1H, d, J=12 Hz, CH2),
3.66-3.68 (1H, d, J=12 Hz, CH2), 7.26-7.65 (9H, m, Ar -H),
8.70 (1H, s, NH), 10.66 (1H, s, NH); 13C NMR (DMSO): ꢁC
175.6, 156.3, 139.4, 135.0, 133.3, 132.4, 129.9, 129.4, 129.0,
129.0, 128.6, 127.3, 126.1, 126.1, 68.6, 31.1 ppm.
[4]
[5]
Enebäck, C. Hydantoins from chalcone oxides. Acta. Chem.
Scand., 1958, 12, 1528.
Muccioli, G. G.; Poupaert, J. H.; Wouters, J.; Norberg, B.; Poppitz,
W.; Scriba, G. K. E.; Lambert, D. M. A rapid and efficient
microwave-assisted synthesis of hydantoins and thiohydantoins.
Tetrahedron, 2003, 59, 1301-1307.
[6]
Bhat, B. A.; Dhar, K. L.; Puri, S. C.; Spiteller, M. A novel one-pot
rearrangement reaction of 2,3-epoxydiaryl ketones: Synthesis of
(±)-5,5-disubstituted imidazolones and 5,5-disubstituted hydantoins
Synlett., 2006, 17, 2723.
(a) Luche, J. L. Synthetic Organic Sonochemistry, Plenum, New
York, NY, 1998; (b) Mason, T. J.; Peters, D. Practical
Sonochemistry, 2nd ed., Ellis Horwood, London, 2002.
(a) Li, J.T.; Wang, S. X.; Chen, G. F.; Li, T. S. Some application of
ultrasound irradiation in organic synthesis. Curr. Org. Synth., 2005,
2, 175; (b) Ratoarinoro, N.; Wilhelm, A. M.; Berlan, J.; Delmas, H.
Effects of ultrasound emitter type and power on a heterogeneous
reaction. Chem. Eng. J., 1992, 50, 27.
Goodson, L.H.; Honigberg, I. L.; Lehman, J. J.; Burton W. H.
Potential growth antagonists I. Hydantoins and disubstituted
glycines. J. Org. Chem., 1960, 25, 1920.
Enebäck, C.; Alberty, J. E. Synthesis and anticonvulsive properties
of substituted 5-phenyl-5-benzyl-hydantoins. Arzneim. Forsch.,
1965, 15, 1231.
Compound 3g
5-(2-methoxybenzyl)-5-phenyl-2-thioxoimidazolidin-4-one
Yellow solid, m.p.156 C; m/z (ESI): 313 [M+H]+; H
NMR (DMSO): ꢁH 3.23-3.25 (1H, d, J=12 Hz, CH2), 3.48-
3.50 (1H, d, J=12 Hz, CH2), 3.76 (3H, s, OCH3), 6.83-7.59
(9H, m, Ar -H), 10.48 (1H, s, NH), 11.50 (1H, s, NH); 13C
NMR (DMSO): ꢁC 181.5, 176.2, 158.3, 138.6, 131.9, 129.2,
129.1, 129.1, 128.7, 126.0, 126.0, 123.0, 120.4, 111.4, 71.7,
56.0, 37.7 ppm.
o
1
[7]
[8]
[9]
Compound 3h
5-(4-methoxybenzyl)-5-phenyl-2-thioxoimidazolidin-4-one
[10]
[11]
Yellow solid, m.p.210 C; m/z (ESI): 313 [M+H]+; H
NMR (DMSO): ꢁH 2.51-2.53 (1H, d, J=12 Hz, CH2), 3.02-
3.04 (1H, d, J=12 Hz, CH2), 3.73 (3H, s, OCH3), 6.85-7.59
(9H, m, Ar -H), 10.77 (1H, s, NH), 11.50 (1H, s, NH); 13C
NMR (DMSO): ꢁC 181.6, 176.1, 158.9, 138.5, 131.8, 131.8,
o
1
(a) Jörlander, H. Ifber das anisoyl-phenyl-oxidolthan und andere
keto-oxidoverbindungen. Ber., 1917, 50, 406; (b) Dunnavant, W.
R.; James, F. L. Molecular rearrangements. I. The base-catalyzed
condensation of benzil with urea. J. Am. Chem. Soc., 1956, 78,
2740.